Claire Slusarz, NP

Annabel Endean, NP, is a dedicated Nurse Practitioner specializing in the diagnosis and management of gastroesophageal reflux disease (GERD) and hiatal hernias. With a focus on evidence-based assessments and personalized treatment plans, she aims to optimize patient outcomes and improve overall quality of life. Collaborating with a multidisciplinary team, Annabel emphasizes a patient-centered approach that includes education and empowerment, guiding patients to make informed decisions about their care. Her expertise encompasses a range of gastrointestinal disorders, ensuring comprehensive care that addresses both acute and chronic aspects of these conditions. Generated from the website

Michal Bar-Natan, MD, is Associate Professor of Clinical Medicine and a member of the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital in New York City. Dr. Bar-Natan graduated cum laude from the Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone Health. In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women’s Hospital (Harvard Medical School) with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms (MPNs) and leukemias.Prior to this position Dr. Bar-Natan served as Associate Professor of Medicine at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and as the leader of the Acute Lymphoblastic Leukemia program at the Mt. Sinai Tisch Cancer Institute. Dr. Bar-Natan’s focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials for patients with these conditions. She leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serves as the PI and co-investigator on many clinical trials for acute leukemias and myeloproliferative neoplasms.

Dr. Christina Shayevitz received her B.A. degree from University of California, San Diego in 2008, on the Dean’s Honor Roll. She wished for change in seasons and snow, and moved to Syracuse, New York where she attended SUNY Upstate Medical University. Following the completion of her medical degree, she attended residency in Adult Psychiatry at Mount Sinai Beth Israel where she also served as the Co-Chair of the MSBI House Staff Committee. She fell in love with fast-pace and multicultural New York, and stayed for a fellowship in Consultation-Liaison Psychiatry at NYU/Bellevue Hospital. Dr. Shayevitz also completed the Psychodynamic Therapy Certification Course provided by the New York Medical College Psychoanalytic Program. She now resides in Financial District and is happy to be a part of the Consultation-Liaison Service at the lower Manhattan campus.